Jan. 28, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T ™) products for ...
Canaccord Genuity analyst John Newman maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report) today and set a price target of $14.00. The company’s shares closed yesterday at ...
Allogene Therapeutics (ALLO) announced that the U.S. Food and Drug Administration, FDA, has cleared its Investigational New Drug, IND, application for a rheumatology basket study of ALLO-329 ...
Japan’s JERA, a joint venture between Tokyo Electric Power Company (Tepco) and Chubu Electric Power Company, has signed a $450 million liquefied natural gas supply deal with the Adnoc Gas of the ...
Japan’s LNG buyer JERA is set to expand liquefied natural gas (LNG) imports from the US to diversify its supply chain and meet the rising demand from data centres and AI sectors, reported Reuters.
Ltd. (“JERA Global Markets”). The agreement reaffirms ADNOC Gas' position as a reliable global supplier of clean energy while supporting Japan's energy requirements. The LNG will be supplied from ...
DAVOS, Switzerland (Reuters) -Japan's top LNG buyer, JERA, plans to increase its purchases of liquefied natural gas from the United States to diversify its supply and meet demand growth spurred by ...
Japan’s biggest top LNG buyer, JERA, plans to increase its purchases of liquefied natural gas from the United States to diversify its supply and meet demand growth spurred by data centres and AI, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results